Holding(s) in Company

Holding(s) in Company

06 November 2020

IQE plc
(“IQE” or the “Company”)

Holding(s) in Company

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i
 
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : IQE PLC
1b. Please indicate if the issuer is a non-UK issuer  (please mark with an “X” if appropriate)
Non-UK issuer  
2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments  
An event changing the breakdown of voting rights  
Other (please specify)iii:  
3. Details of person subject to the notification obligation iv
Name T. Rowe Price Associates, Inc.
City and country of registered office (if applicable) Baltimore, Maryland, USA
4. Full name of shareholder(s) (if different from 3.)v
Name T. Rowe Price International Ltd
City and country of registered office (if applicable) London, United Kingdom
5. Date on which the threshold was crossed or reached vi : 03 November 2020
6. Date on which issuer notified (DD/MM/YYYY): 05 November 2020
7. Total positions of person(s) subject to the notification obligation
  % of voting rights attached to shares (total of 8. A) % of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B) Total number of voting rights of issuervii
Resulting situation on the date on which threshold was crossed or reached 14.74% 2.22% 16.96% 800,087,575
Position of previous notification (if
applicable)
15.73% 1.25% 16.99%  



8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii
A: Voting rights attached to shares
Class/type of
shares

ISIN code (if possible)
Number of voting rights ix % of voting rights
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
GB0009619924   117,933,947   14.74%
         
         
SUBTOTAL 8. A 117,933,947 14.74%
 

 
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument Expiration
date
x
Exercise/
Conversion Period
xi
Number of voting rights that may be acquired if the instrument is
exercised/converted.
% of voting rights
Shares on loan N/A Right of recall on demand 17,818,805 2.22%
         
         
    SUBTOTAL 8. B 1 17,818,805 2.22%
 

 
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument Expiration
date
x
Exercise/
Conversion Period
xi
Physical or cash
settlement xii
Number of voting rights % of voting rights
           
           
           
      SUBTOTAL 8.B.2    
 

 

 


9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii  
Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)
X
Name xv % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable threshold
   T. Rowe Price Associates, Inc. 6.33% 1.10% 7.43%
    T. Rowe Price International Ltd 8.40% 1.12% 9.52%
       
       
       
 
10. In case of proxy voting, please identify:
Name of the proxy holder  
The number and % of voting rights held  
The date until which the voting rights will be held  
 
11. Additional information xvi
 


Place of completion Baltimore, Maryland, USA
Date of completion 05 November 2020

Companies

IQE (IQE)
UK 100

Latest directors dealings